ERBB2 and cancer: Previous studies have however raised concerns about concordance and stability of gene signatures for ER/PR/HER2 negative[15] and ER positive/HER2 negative cancers[16,17].Another concern is that expression levels of single and multi-gene signatures are unstable[18–20] In a previous study, we found that the concordance of outcome assignment between eight gene expression signatures was low [20].